Cite
HARVARD Citation
Sehmbey, G. et al. (n.d.). S3326 Continuation of Mesalamine with Anti-Tumor Necrosis Factor in Inflammatory Bowel Disease: A Two Center Analysis of Treatment Trends and Cost. American journal of gastroenterology. pp. S1370-S1371. [Online].